Argenx (ARGX) AnalysisCompany Overview: Argenx NASDAQ:ARGX is making significant strides in the field of autoimmune treatments, especially following the FDA approval of VYVGART Hytrulo for chronic inflammatory demyelinating polyneuropathy (CIDP) on June 21st. This approval not only enhances Argenx's product portfolio b
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
12.8 EUR
770.13 M EUR
2.02 B EUR
61.01 M
About ARGENX SE
Sector
Industry
CEO
Tim van Hauwermeiren
Website
Headquarters
Amsterdam
Founded
2008
ISIN
NL0010832176
FIGI
BBG006MF2DW2
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Argenx Lead as Chugai's Muscle Disease Treatment DisappointsIn a whirlwind of market reactions, biotech stocks Argenx ( NASDAQ:ARGX ) and Immunovant ( NASDAQ:IMVT ) emerged as frontrunners on Thursday, propelled by disappointing results from Japanese rival Chugai Pharmaceutical. The contrast in fortunes underscores the high stakes and volatile nature of the
ARGX Bullish Trade Setup Looking to place some longs on ARGX. Argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.n top 10: 10 8 25.0% 6 (0.35%) 6 (0.35%) 0.0%
Funds Hol
Will ARGX break out ascending channelWill Argenx be Wall streets next Biotech unicorn? I am extremely bullish!
Biotech is booming business. Monoclonal antibodies are revolutionizing pharma industry.
Again great news for Argenx.
01feb2021
launches new global offering to raise funds after 'Go' decisions for CIDP treatment trials
ARGX Buy Signal To Watch .After forming the gap at the market open , NASDAQ:ARGX has succeeded to close above the Red Line around the 206.5 .
IF it succeeds today or in an upcoming day to close with bullish strength considerably above the green line at around the 217 mark ,I think It is likely to continue up to around th
argenx reports positive topline results from Phase 2The data showed a clinically meaningful and statistically significant benefit of ARGX-113 over placebo. In addition, ARGX-113 was found to have a favorable tolerability profile consistent with that observed in the Phase 1 study.
“These data demonstrate a rapid and sustained benefit in disease score
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ARGX is featured.
Related stocks
Frequently Asked Questions
The current price of ARGX is 530.0 EUR — it has increased by 0.91% in the past 24 hours. Watch ARGENX SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ARGENX SE stocks are traded under the ticker ARGX.
ARGX stock has risen by 4.85% compared to the previous week, the month change is a −0.97% fall, over the last year ARGENX SE has showed a 50.40% increase.
We've gathered analysts' opinions on ARGENX SE future price: according to them, ARGX price has a max estimate of 983.86 EUR and a min estimate of 540.00 EUR. Watch ARGX chart and read a more detailed ARGENX SE stock forecast: see what analysts think of ARGENX SE and suggest that you do with its stocks.
ARGX reached its all-time high on Jan 14, 2025 with the price of 658.0 EUR, and its all-time low was 6.2 EUR and was reached on Oct 16, 2014. View more price dynamics on ARGX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ARGX stock is 1.90% volatile and has beta coefficient of 0.61. Track ARGENX SE stock price on the chart and check out the list of the most volatile stocks — is ARGENX SE there?
Today ARGENX SE has the market capitalization of 32.20 B, it has decreased by −8.31% over the last week.
Yes, you can track ARGENX SE financials in yearly and quarterly reports right on TradingView.
ARGENX SE is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
ARGX net income for the last half-year is 799.60 M EUR, while the previous report showed −30.10 M EUR of net income which accounts for 2.76 K% change. Track more ARGENX SE financial stats to get the full picture.
No, ARGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 1.6 K employees. See our rating of the largest employees — is ARGENX SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARGENX SE EBITDA is −54.06 M EUR, and current EBITDA margin is −2.12%. See more stats in ARGENX SE financial statements.
Like other stocks, ARGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARGENX SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARGENX SE technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARGENX SE stock shows the buy signal. See more of ARGENX SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.